BIRC4 mutation: An important rare cause of uveitis

Journal of Clinical Rheumatology

Volumn 21, Issue 8, 2015, Pages 444-447

  Basiaga, Matthew L ^a   Weiss, Pamela F ^a   Behrens, Edward M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BIRC4 mutation; Uveitis; XIAP deficiency; XLP 2

Indexed keywords

ADALIMUMAB; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; RITUXIMAB; X LINKED INHIBITOR OF APOPTOSIS; ANTIRHEUMATIC AGENT; XIAP PROTEIN, HUMAN;

ARTICLE; CASE REPORT; CHILD; DIARRHEA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; GENE MUTATION; HISTIOCYTOSIS; HUMAN; IRIDOCYCLITIS; MALE; PRIORITY JOURNAL; UVEITIS; VOMITING; COMPLICATION; DEFICIENCY; GENETIC DISEASES, X-LINKED; GENETICS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MUTATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADALIMUMAB; ANTIRHEUMATIC AGENTS; CHILD; CYCLOSPORINE; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC DISEASES, X-LINKED; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MUTATION; TREATMENT OUTCOME; UVEITIS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84948719525     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000327     Document Type: Article

References (15)

1. Speckmann C, Lehmberg K, Albert MH, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013; 149:133-141.
2. Wang X, Kuivaniemi H, Bonavita G, et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002;46:3041-3045.
3. Krieg A, Correa RG, Garrison JB, et al. XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A. 2009;106: 14524-14529.
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411: 603-606.
5. Tanabe T, Chamaillard M, Ogura Y, et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 2004;23:1587-1597.
6. Sumegi J, Huang D, Lanyi A, et al. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96: 3118-3125.
7. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129-135.
8. Arico M, Imashuku S, Clementi R, et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood. 2001;97:1131-1133.
9. Rigaud S, Fondanèche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444: 110-114.
10. Pachlopnik Schmid J, Canioni D, Moshous D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 2011;117:1522-1529.
11. Ammann S, Elling R, Gyrd-Hansen M, et al. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency. Clin Exp Immunol. 2014;176:394-400.
12. Standing A, et al. A novel mutation in the X-linked inhibitor of apoptosis protein causing a multi-system autoinflammatory disorder. Ann Paediatr Rheumatol. 2012;1:227-230.
13. Marsh RA, Rao K, Satwani P, et al. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Blood. 2013;121:877-883.
14. Worth AJ, Nikolajeva O, Chiesa R, et al. Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis. Blood. 2013;121: 4966-4968.
15. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011; 13:255-262.